Lista de obras -

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.

artículo científico publicado en 2016

An overview of anti-diabetic plants used in Gabon: Pharmacology and Toxicology.

artículo científico publicado en 2018

Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test

artículo científico publicado en 2013

Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function

artículo científico publicado en 2013

Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells

artículo científico publicado en 2020

Evidence that diclofenac and celecoxib are thyroid hormone receptor beta antagonists

artículo científico publicado en 2016

Harnessing the benefits of PPARβ/δ agonists.

artículo científico publicado en 2013

In silico modelling of prostacyclin and other lipid mediators to nuclear receptors reveal novel thyroid hormone receptor antagonist properties

artículo científico publicado en 2015

LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression

artículo científico publicado en 2013

Linking phospholipase C isoforms with differentiation function in human vascular smooth muscle cells

artículo científico publicado en 2013

Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies.

artículo científico publicado en 2016

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

artículo científico publicado en 2015

Role of prostacyclin in pulmonary hypertension.

artículo científico publicado en 2014

The Non-Genomic Effects of the PPARβδ agonist GW0742 on STZ treated rat aorta.

artículo científico publicado en 2016

Thyroid Hormone Receptor Antagonists: From Environmental Pollution to Novel Small Molecules

artículo científico publicado en 2017

Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population

artículo científico publicado en 2020

Lista de obras de

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.

An overview of anti-diabetic plants used in Gabon: Pharmacology and Toxicology.

Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test

Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function

Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells

Evidence that diclofenac and celecoxib are thyroid hormone receptor beta antagonists

Harnessing the benefits of PPARβ/δ agonists.

In silico modelling of prostacyclin and other lipid mediators to nuclear receptors reveal novel thyroid hormone receptor antagonist properties

LC-MS/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression

Linking phospholipase C isoforms with differentiation function in human vascular smooth muscle cells

Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies.

Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

Role of prostacyclin in pulmonary hypertension.

The Non-Genomic Effects of the PPARβδ agonist GW0742 on STZ treated rat aorta.

Thyroid Hormone Receptor Antagonists: From Environmental Pollution to Novel Small Molecules

Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population